Stock Price
0.75
Daily Change
0.03 4.17%
Monthly
63.04%
Yearly
697.87%
Q2 Forecast
0.71

Starpharma Holdings reported AUD-873K in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Medical Developments International AUD -36K 12.96M Dec/2025
Mesoblast USD -27.75M 14.36M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025